Steven Cohen (Trades, Portfolio)'s investment firm, Point72, has recently expanded its portfolio with the addition of Cidara Therapeutics Inc (NASDAQ:CDTX). On December 31, 2023, Point72 acquired 1,250,228 shares of the biotechnology company, reflecting a new position in the firm's diverse investment landscape. The transaction was executed at a trade price of $0.794 per share, marking a strategic move by one of the industry's leading investment entities.
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Free Report) – Investment analysts at HC Wainwright decreased their Q3 2023 EPS estimates for Cidara Therapeutics in a research note issued to investors on Monday, August 7th. HC Wainwright analyst E. Arce now expects that the biotechnology company will post earnings per share of ($0.14) for the quarter, down […]